What price per share was used for the Core Scientific (CORZ) tax withholding?

The Form 4 reports that the 87,355 withheld shares were valued at $19.08 per share. This price is used to calculate the value of shares applied to satisfy the CEO’s withholding tax obligations upon vesting of restricted stock units.

Core Scientific (NASDAQ: CORZ) CEO has 87,355 shares withheld

Filing Impact

(Very High)

Filing Sentiment

(Neutral)

Form Type

Rhea-AI Filing Summary

Core Scientific CEO Adam Taylor reported a routine tax-related share disposition. On the vesting of restricted stock units, 87,355 shares of Common Stock were withheld at $19.08 per share to cover withholding tax obligations.

After this non-market transaction, Taylor directly holds 4,470,033 shares of Core Scientific common stock. Because the shares were withheld for taxes rather than sold on the open market, this filing reflects compensation and tax mechanics more than a change in investment view.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Sullivan Adam Taylor

Role Chief Executive Officer

Type	Security	Shares	Price	Value
Tax Withholding	Common Stock	87,355	$19.08	$1.67M

Holdings After Transaction: Common Stock — 4,470,033 shares (Direct)

Footnotes (1)

[object Object]

Key Figures

Shares withheld for taxes: 87,355 shares Withholding price per share: $19.08 per share Shares held after transaction: 4,470,033 shares +1 more

4 metrics

Shares withheld for taxes 87,355 shares Withheld upon RSU vesting to satisfy tax obligations

Withholding price per share $19.08 per share Value assigned to withheld shares for tax purposes

Shares held after transaction 4,470,033 shares CEO’s direct Core Scientific common stock holdings post-transaction

Transaction date 2026-04-15 Date of tax-withholding disposition on RSU vesting

Key Terms

restricted stock units, withholding tax obligations, Form 4, Chief Executive Officer

4 terms

restricted stock units financial

"upon the vesting of restricted stock units"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

withholding tax obligations financial

"shares withheld to satisfy withholding tax obligations"

Form 4 regulatory

"The Form 4 reports that the 87,355 withheld shares"

Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

Chief Executive Officer financial

"Adam Taylor, the Chief Executive Officer of Core Scientific"

A chief executive officer (CEO) is the top leader of a company, responsible for making major decisions, setting goals, and guiding the organization’s overall direction. Think of the CEO as the captain of a ship, steering it toward success. Investors pay close attention to the CEO because their leadership and strategy can significantly influence the company's performance and future growth.

Form 4 Insider Transactions: What Each Field Means →

04/17/2026 - 09:50 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Sullivan Adam Taylor

(Last)

(First)

(Middle)

C/O CORE SCIENTIFIC, INC.

838 WALKER ROAD, SUITE 21-2105

(Street)

DOVER

DELAWARE

19904

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Core Scientific, Inc./tx [ CORZ ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	Chief Executive Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
04/15/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	04/15/2026		F⁽¹⁾		87,355	D	$19.08	4,470,033	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. Represents shares withheld to satisfy withholding tax obligations upon the vesting of restricted stock units.

	/s/ Todd DuChene, as Attorney-in-Fact	04/17/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What insider transaction did Core Scientific (CORZ) report for its CEO?

Core Scientific CEO Adam Taylor reported a disposition where 87,355 shares were withheld to cover taxes on vested restricted stock units. This was a non-market transaction linked to equity compensation, not an open-market stock sale by the executive.

Was the Core Scientific (CORZ) CEO’s Form 4 transaction an open-market sale?

No, the Form 4 shows shares withheld for tax obligations, not an open-market sale. The 87,355 shares were retained by the company to satisfy withholding taxes from restricted stock unit vesting, a common equity compensation mechanism.

How many Core Scientific (CORZ) shares does the CEO hold after this filing?

After the tax-withholding disposition, CEO Adam Taylor directly holds 4,470,033 shares of Core Scientific common stock. This post-transaction balance is disclosed in the Form 4 and provides context for the scale of the tax-related share withholding.

What does the footnote in the Core Scientific (CORZ) Form 4 explain?

The footnote explains that the reported shares represent stock withheld to satisfy withholding tax obligations on vesting restricted stock units. This clarifies the disposition is a compensation-related tax event, not a discretionary purchase or sale decision by the CEO in the market.